JP2022505184A5 - - Google Patents

Info

Publication number
JP2022505184A5
JP2022505184A5 JP2021521130A JP2021521130A JP2022505184A5 JP 2022505184 A5 JP2022505184 A5 JP 2022505184A5 JP 2021521130 A JP2021521130 A JP 2021521130A JP 2021521130 A JP2021521130 A JP 2021521130A JP 2022505184 A5 JP2022505184 A5 JP 2022505184A5
Authority
JP
Japan
Prior art keywords
day
composition according
pharmaceutically acceptable
acceptable salt
multiple sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021521130A
Other languages
English (en)
Japanese (ja)
Other versions
JP7430719B2 (ja
JP2022505184A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056948 external-priority patent/WO2020081941A1/en
Publication of JP2022505184A publication Critical patent/JP2022505184A/ja
Publication of JP2022505184A5 publication Critical patent/JP2022505184A5/ja
Application granted granted Critical
Publication of JP7430719B2 publication Critical patent/JP7430719B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021521130A 2018-10-19 2019-10-18 イブジラストを用いて眼疾患/障害または損傷を治療する方法 Active JP7430719B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862748148P 2018-10-19 2018-10-19
US62/748,148 2018-10-19
PCT/US2019/056948 WO2020081941A1 (en) 2018-10-19 2019-10-18 Methods of treating ophthalmic disease/disorder or injury with ibudilast

Publications (3)

Publication Number Publication Date
JP2022505184A JP2022505184A (ja) 2022-01-14
JP2022505184A5 true JP2022505184A5 (cg-RX-API-DMAC7.html) 2022-10-11
JP7430719B2 JP7430719B2 (ja) 2024-02-13

Family

ID=68503211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521130A Active JP7430719B2 (ja) 2018-10-19 2019-10-18 イブジラストを用いて眼疾患/障害または損傷を治療する方法

Country Status (7)

Country Link
US (1) US11154540B2 (cg-RX-API-DMAC7.html)
EP (1) EP3866788B1 (cg-RX-API-DMAC7.html)
JP (1) JP7430719B2 (cg-RX-API-DMAC7.html)
CN (1) CN112804999B (cg-RX-API-DMAC7.html)
CA (1) CA3116577A1 (cg-RX-API-DMAC7.html)
ES (1) ES2970996T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020081941A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024528731A (ja) 2021-07-26 2024-07-30 メディシノバ・インコーポレイテッド 眼癌転移を予防するためのイブジラスト
US12042485B2 (en) 2021-10-07 2024-07-23 Medicinova, Inc. Methods of minimizing cancer metastasis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8562198A (en) 1998-08-10 2000-03-06 Kyorin Pharmaceutical Co. Ltd. Remedies for multiple sclerosis
WO2006063048A2 (en) 2004-12-06 2006-06-15 Avigen, Inc. Ibudilast for treating neuropathic pain and associated syndromes
US8067433B2 (en) * 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
EP2139492A1 (en) * 2007-03-30 2010-01-06 Fovea Pharmaceuticals SA Methods for treating neovascular ocular diseases
CA2693697C (en) * 2007-07-11 2017-07-25 Medicinova, Inc. Treatment of progressive neurodegenerative disease with ibudilast
IN2014MN01552A (cg-RX-API-DMAC7.html) * 2012-02-27 2015-05-08 Rohto Pharma
TW201406707A (zh) * 2012-05-04 2014-02-16 Acucela Inc 用以治療糖尿病性視網膜病變及其他眼部疾病之方法
US10258611B2 (en) * 2014-11-26 2019-04-16 Medicinova, Inc. Combination of ibudilast and riluzole and methods of using same

Similar Documents

Publication Publication Date Title
JP2021527092A5 (cg-RX-API-DMAC7.html)
JP6196041B2 (ja) 大うつ病を有する患者において減量療法を提供する方法
JP2015505564A5 (cg-RX-API-DMAC7.html)
CN107530317A (zh) 大麻素类和n‑酰基乙醇胺的组合
JP2022550919A5 (cg-RX-API-DMAC7.html)
JP2021512149A5 (cg-RX-API-DMAC7.html)
MX2020012377A (es) Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades.
JP2016510343A5 (cg-RX-API-DMAC7.html)
JP2020522560A5 (cg-RX-API-DMAC7.html)
RU2018146504A (ru) Лечение внутрипеченочных холестатических заболеваний
MX2024007642A (es) Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades.
JP2016505050A5 (cg-RX-API-DMAC7.html)
JP2019507786A5 (cg-RX-API-DMAC7.html)
JP2025506201A5 (cg-RX-API-DMAC7.html)
JP2024528731A5 (cg-RX-API-DMAC7.html)
CA3138389A1 (en) Rebamipide for use in prevention and/or treatment of synucleinopathies
WO2018229738A1 (en) Treatment for migraine
JP2024531799A5 (cg-RX-API-DMAC7.html)
JP2021512086A5 (cg-RX-API-DMAC7.html)
JP2019535830A5 (cg-RX-API-DMAC7.html)
JP2022504435A5 (cg-RX-API-DMAC7.html)
IE851848L (en) Propiophenone compound against sexual dysfunction
CN105209044A (zh) 用于疼痛病症的新的治疗性米氮平组合物
CN102813924B (zh) 一种基于青藤碱的用于镇痛的药物组合产品
JP7527662B2 (ja) ピモジドとメトトレキサートの医薬組成物、及びその使用